baber/WOPTO huggingface dataset:
Patent DK-1966371-T3 (DK)
Inventor: MALLET ROBERT W
IPC: C12N9/00
Filed: 2006-12-21
Granted: 2011-12-12
Abstract: Methods for converting prethrombin-1 to thrombin are disclosed. An aqueous solution of prethrombin-1 is applied to oscutarin-C immobilized on a solid support so as to provide from 500 mg to 4000 mg of prethrombin-1 per mL of the solid support and a contact time between the prethrombin-1 and the oscutarin-C of from 1.8 to 3.5 minutes. The resulting active thrombin may be captured on an ion exchange chromatography medium or an affinity chromatography medium.
Patent DK-2033702-T3 (DK)
Inventor: WINKLER HERMANN DR
IPC: B01D53/02
Filed: 2007-09-04
Granted: 2011-05-02
Abstract: The mercury present in the flue gas is brought in contact with activated carbon. The mercury is adsorbed in the activated carbon. The adsorbed mercury is separated from the carbon. The carbon is brought in contact with an oxidizing reagent such as hypochlorite, chlorine dioxide or chlorine gas. The adsorbed mercury is desorbed and dissolves in the form of Hg 2> +>in a solution. The Hg 2> +>enriched solution is separated from the carbon. The Hg 2> +>is removed from the solution by mixing with an organosulfide precipitating reagent or bringing the solution to contact with an ion exchanger.
Patent DK-2123271-T3 (DK)
Inventor: YAMASHITA MAKOTO
IPC: A61K31/351
Filed: 2008-03-03
Granted: 2012-01-23
Abstract: A therapeutic or prophylactic for H5N1 influenza is provided.  Specifically disclosed is a therapeutic or prophylactic for H5N1 influenza comprising as an active ingredient a compound represented by the general formula (I):   
wherein R 1  and R 2  represent H or alkanoyl; X represents a halogen atom, OH, alkoxy or alkanoyloxy; and R 3  represents H or alkyl; PROVIDED THAT compounds of formula (I) wherein each of R 1  and R 2  is H, X is OH, and R 3  is H are excluded.
Patent DK-2140920-T3 (DK)
Inventor: MEINZINGER RUPERT
IPC: B01D19/00
Filed: 2009-06-25
Granted: 2012-07-23
Abstract: The swirl element (1) has a helical or spiral shaped flow guiding element (8) by which an angular impulse is applied to fluid flowed through an inlet valve. The flow guiding element is arranged on an outer peripheral surface and/or on inner surface of a support structure (2). The support structure exhibits a cylindrical or tubular shape, and exhibits a diameter larger than a diameter at a flow upstream-sided end section (4). The support structure has a cylindrical hollow body. The flow guiding element is connected with the support structure at a longitudinal side of the flow guiding element. Independent claims are also included for the following: (1) an inlet valve for bringing a fluid into a degassing device (2) a method for degassing a fluid by an inlet valve.
Patent DK-2658871-T3 (DK)
Inventor: ELIAS KATHLEEN ANN
IPC: C07K16/28
Filed: 2011-12-30
Granted: 2018-08-13
Abstract: Isolated antibodies that bind to human CD38 and cynomolgus CD38 are disclosed. Also disclosed are pharmaceutical compositions comprising the disclosed antibodies, and therapeutic and diagnostic methods for using the disclosed antibodies.
Patent DK-2897604-T3 (DK)
Inventor: PIERZYNOWSKI STEFAN
IPC: A61K31/198
Filed: 2013-09-19
Granted: 2018-08-06
Abstract: A composition comprising alpha-ketoglutaricacid or a pharmaceutically acceptable salt thereof (AKG), and one or more enzymes selected from a group consisting of a lipase, a protease and an amylase, and medical uses thereof in, neurological and/or neurodegenerative disease, neurological trauma, depression or chronic fatigue syndrome.
Patent DK-3233146-T3 (DK)
Inventor: STIEFEL NIKLAUS
IPC: A61K6/884
Filed: 2016-12-02
Granted: 2018-07-16
Abstract: A resorbable crosslinked form stable membrane containing a composite layer of collagen material and inorganic ceramic particles containing 1.5 to 3.5 weight parts of inorganic ceramic for 1 weight part of collagen material, sandwiched between two layers of elastic pretensed collagen material, wherein the elastic pretensed collagen material is collagen material that has been stretched such as to be in the linear/elastic region of the stress-strain curve, the collagen material comprising 50-100% (w/w) collagen and 0-50% (w/w) elastin.
Patent DK-0385074-T3 (DK)
Inventor: RINGELHAAN OTMAR DIPL-ING
IPC: H04L27/233
Filed: 1990-01-15
Granted: 1993-09-27
Abstract: The demodulation system converts the received signals into an intermediate frequency using a formula expressed in terms of the clock frequency of the modulated information, with signal sampling using a sampling period which corresponds to the reciprocal of the clock frequency. Pref. the intermediate frequency is obtd. from a quarter wavelength of the clock frequency summated with an odd or even multiple of half the clock frequency.
Patent DK-0389180-T3 (DK)
Inventor: ECK CHARLES R
IPC: A61P25/28
Filed: 1990-03-15
Granted: 1995-03-20
Abstract: An octapeptide of the formula: <CHEM> wherein each A1 and A2, independently, is H, C1-12 alkyl, C7-10 phenylalkyl, R1CO (where R1 is C1-20 alkyl, C3-20 alkenyl, C3-20 alkynyl, phenyl, naphthyl, or C7-10 phenylalkyl), or R2OCO (where R2 is C1-10 alkyl or C7-10 phenylalkyl), provided that when one of A1 or A2 is R1CO or R2OCO, the other must be H; A3 is CH2-A6 (where A6 is pentafluorophenyl, naphthyl, pyridyl, phenyl, or o-, m-, or, more preferably, p-substituted phenyl, where the substituent is a halogen, NH2, NO2, OH, or C1-3 alkyl); (I) indicates that tyrosine is iodinated on the phenyl ring at its 3 or 5 carbon positions; A5 is Thr, Ser, Phe, Val,  alpha -aminobutyric acid, or Ile, provided that when A3 is phenyl, A1 is H, and A2 is H, A5 cannot be Val; and A7 is Thr, Trp, or  beta -Nal; or a pharmaceutically acceptable salt thereof.
Patent DK-0412941-T3 (DK)
Inventor: HOULIHAN WILLIAM JOSEPH
IPC: A61P25/00
Filed: 1990-08-07
Granted: 1996-06-24
Abstract: Phospholipids of formula <CHEM> in which Q, n and R3 are as described in the specification, are useful in the treatment of multiple sclerosis.
Patent DK-0440100-T3 (DK)
Inventor: FERRO ALBERTO DR
IPC: A61K38/21
Filed: 1991-01-25
Granted: 1994-11-21
Abstract: Pharmaceutical preparations which contain an immunomodulating protein, for example an interferon, a bile acid derivative and a lipid are described.
Patent DK-0529139-T3 (DK)
Inventor: THILO PEER DR-ING
IPC: G08B25/04
Filed: 1991-08-30
Granted: 1996-08-12
Abstract: A method for transmitting binary data in an alarm signalling system comprising a central station (Z), from which at least one dual line (a, b) originates, by means of which a multiplicity of detectors (M1 to Mn) is connected to the central station (Z), devices in each case formed by means of a comparator (K) and a storage element (Cv; MR) for transmitting and detecting binary data being provided in the central station (Z) and in the detectors (M1 to Mn), the respective comparator switching thresholds being determined by the state of the respective storage elements (Cv; MR) and the state of the respective storage elements (Cv; MR) being determined by the central station (Z) by applying a reference voltage (Ue) to the dual line (a, b). <IMAGE>
Patent DK-0499732-T3 (DK)
Inventor: IBBOTT JACK KENNETH
IPC: C02F1/46
Filed: 1991-05-03
Granted: 1994-08-01
Abstract: The present invention relates to a method and apparatus for treating electrically conductive fluid. Positive (1) and negative (2) electrodes of electrically conductive materials having different electrochemical potentials are spaced apart and electrically isolated from one another so that the only electroconductive connection that develops an electrochemical potential between the electrodes (1,2) is established by fluid to be treated flowing between the electrodes. Such fluid is therefore ionized which will both prevent the precipitation of solids from the fluid which would tend to form a scale on the inner surface of piping through which the fluid flows, and aid in the removal of a previously formed scale. A third electrode (3) is also provided so as to be electroconductively connected with the positive electrode (1) but electrically isolated from the negative electrode (2). Therefore, the third electrode (3) will release metal ions into the fluid. These ions will inhibit the release of compounds into the fluid having a principal element that is the same as that of the metal ions released by the electrode (3). In such a way, the fluid can also be treated to inhibit a particular compound, to which the fluid might be exposed, from dissolving into the fluid. <IMAGE>
Patent DK-0458589-T3 (DK)
Inventor: UENO RYUJI
IPC: A61P43/00
Filed: 1991-05-21
Granted: 1995-04-03
Abstract: A use of an oculo-hypotensively synergistic combination of     (a) a 13,14-dihydro-15-ketoprostaglandin compound, and   (b) a cholinergic agent   for the manufacture of a medicament useful in treatment of ocular hypertension.
Patent DK-0460827-T3 (DK)
Inventor: LAWRENSON MALCOLM JOHN
IPC: C07C15/46
Filed: 1991-05-21
Granted: 1994-11-14
Abstract: This invention relates to a process for the production of alpha, para-dimethyl styrene by catalytic dehydrogenation of para-cymene in the substantial absence of oxygen or an oxidising gas and in the presence of steam. The catalyst used is iron oxide, Fe3O4. The reaction is carried out at a temperature in the range from 500 to 700 DEG C and a pressure from 0.1 to 10 atmospheres. The product is a valuable intermediate for the manufacture of perfumes. <IMAGE>
Patent DK-0514411-T3 (DK)
Inventor: ROBSON KATHRYN JANE HALLOWES
IPC: A61P33/06
Filed: 1991-02-04
Granted: 2001-05-28
Abstract: The invention provides proteins form the merozoite stage of the malaria parasite forming a conserved sequence in a broader sequence, fragments and derivatives thereof, DNA coding for the proteins and processes for the preparation of the proteins and plasmid and viral vectors useful in said processes. The invention also provides antibodies to the proteins and immunological compositions containing them.
Patent DK-0551404-T3 (DK)
Inventor: NIJENHUIS DERK
IPC: B62D61/12
Filed: 1991-10-11
Granted: 1994-12-05
Abstract: PCT No. PCT/NL91/00198 Sec. 371 Date Jun. 1, 1993 Sec. 102(e) Date Jun. 1, 1993 PCT Filed Oct. 11, 1991 PCT Pub. No. WO92/06882 PCT Pub. Date Apr. 30, 1992.A vehicle is provided with a number of retractable supporting wheels. When this vehicle is coupled to a load, the supporting wheels can be lifted off the ground so that a very easily controllable assembly is produced. Through the correct selection of the position of the center of gravity, the wheel pressure on the drive wheels is as great as possible. Due to the fact that the supporting wheels can be raised independently, coupling with a load is facilitated.
Patent DK-0555518-T3 (DK)
Inventor: KRUG THOMAS DR
IPC: C23C14/56
Filed: 1992-07-31
Granted: 1997-03-17
Abstract: The invention relates to a method for the aftertreatment of an oxide coating, and specifically an SiOx coating on a synthetic film. In this aftertreatment the oxide coating is exposed to a plasma whose particles effect positive changes of the oxide coating.
Patent DK-0542059-T3 (DK)
Inventor: MUELLER-GLIEMANN MATTHIAS DR
IPC: C07D401/10
Filed: 1992-10-30
Granted: 1996-07-22
Abstract: Substituted biphenylpyridones of the general formula <IMAGE> in which R<1>, R<2>, R<3>, R<4>, R<5> and A have the stated meanings, and D is a radical of the formula <IMAGE> in which R<13> and R<14> have the stated meanings, can be prepared by alkylation of pyridones on the nitrogen. The substituted biphenylpyridones are suitable as active ingredients in pharmaceutical compositions, especially in pharmaceutical compositions which lower blood pressure and have antiatherosclerotic effects.
Patent DK-0523978-T3 (DK)
Inventor: JONES DAVID S
IPC: C07C69/78
Filed: 1992-07-15
Granted: 1999-11-01
Abstract: Phosphoramidites of the formula <CHEM> where R is a base-labile protecting group, R<1> and R<2> are individually alkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 8 carbon atoms, or aryl of 6 to 20 carbon atoms or are joined together to form with the nitrogen atom a cyclic structure of 4-7 carbon atoms and 0 to 1 annular chalcogen atoms of atomic number 8 to 16, G is a hydrocarbylene group of 1 to 20 carbon atoms and Z is a hydroxy-protected vicinal diol group bound to G by one of the vicinal diol carbon atoms or a disulfide group and bound to G by one of the sulfur atoms of the disulfide group, with the proviso that G is of at least 4 carbon atoms when Z is said disulfide group are used in conventional automated oligonucleotide synthesis to introduce a functional aldehyde or thiol group on the 5 min end of the oligonucleotide to thereby provide a reactive site on the oligonucleotide that may be used to conjugate the oligonucleotide to molecules that contain a free amino group or an electrophilic center reactive with a thiol group.
Patent DK-0559783-T3 (DK)
Inventor: SATYANARAYANA GUPTA D V
IPC: C09K8/92
Filed: 1991-12-03
Granted: 1997-11-03
Abstract: Encapsulations comprised of a breaker enclosed within a membrane are utilized to break fluids used to fracture subterranean formations. The membrane of the encapsulation is permeable to at least one fluid in the subterranean formation or injected with the breaker such that the breaker diffuses through the membrane into the fracturing fluid. Thus, controlled amounts of breaker are released into the fracturing fluid.
Patent DK-0525152-T3 (DK)
Inventor: DAVIS ROBERT BERNARD
IPC: D04H1/4334
Filed: 1992-02-17
Granted: 1996-05-13
Abstract: This invention relates to a method of manufacturing an article of paper machine clothing suitable for use in the pressing section of a papermaking machine, comprising treating fibres of a polyamide material with an aqueous solution of aldehyde in the presence of a catalyst to effect partial cross-linking of the polyamide material, and attaching the fibres in the form of a fibrous batt to a fabric by needling.
Patent DK-0619865-T3 (DK)
Inventor: SUTTON DAVID MICHAEL
IPC: F23N5/20
Filed: 1992-04-16
Granted: 1999-08-30
Abstract: A thermoelectric sensor assembly 1 for use with a flamestrip 9 in a fuel gas burner. The sensor assembly may be in the form of a probe 2 having temperature sensors 5a,b,c,d downstream of the flamestrip 9 in and adjacent the flame region, and temperature sensors 6a,b,c upstream of the flamestrip. A voltage output signal from the sensor assembly is used as an indication of the aeration of the flame and/or of flame establishment and/or flame failure and/or flame lightback.
Patent DK-0574345-T3 (DK)
Inventor: BARBOSA NOLASCO NUNO RUA DAS A
IPC: C12Q1/6804
Filed: 1993-06-10
Granted: 2005-10-03
Abstract: Based on the immobilisation of the pathogen by using antibodies attached to the inner surface of the cups of a microtitration plate, with subsequent synthesis, on the same plate, of the complementary DNA with a fragment of the genom of viral or subviral pathogens and subsequent enzymatic amplification on the same plate, then proceeding to quantify the products of amplification by using spectrophotometric techniques, also carried out on the same plate, and finally, the identification of the products of amplification by means of electrophoretic techniques. <IMAGE>
Patent DK-0577796-T3 (DK)
Inventor: MOSER HANSJUERG
IPC: B23Q16/00
Filed: 1993-01-25
Granted: 1999-06-28
Abstract: PCT No. PCT/CH93/00019 Sec. 371 Date Jan. 12, 1994 Sec. 102(e) Date Jan. 12, 1994 PCT Filed Jan. 25, 1993 PCT Pub. No. WO93/14897 PCT Pub. Date Aug. 5, 1993.The collet stop (1) comprises a clamping disk (15) placeable on the edge (17) of a collet (2) and a chuck body (21) displaceable relative to this clamping disk, having three radially unscrewable tapped bolts (25, 26, 27) which rest against the rearward ends of the slots (6) of a collet. By means of a tightening screw (31), the chuck body (21) can be displaced relative to the clamping disk (15), and the conical ends (34), provided with a hexagonal socket, of the tapped bolts caused to rest against the slot ends. Screwed into the tightening screw (31) is a threaded rod (48) which is provided at its end with a stop disk (52) for the workpiece to be machined. The collet is not crushed or deformed by the collet stop, the collet stop being insertable as a whole into the collet from the rear. As a result of the conical ends (34) of the tapped bolts (25), the collet stop (1) rests against all three ends (38) of the slots (6) of the collet.
Patent DK-0633963-T3 (DK)
Inventor: PHAN DEAN VAN
IPC: D21H21/20
Filed: 1993-03-29
Granted: 1997-09-01
Abstract: Tissue paper webs useful in the manufacture of soft, absorbent products such as napkins, facial tissues, and sanitary tissues, and processes for making the webs. The tissue paper webs comprise papermaking fibers, a biodegradable quaternized amine-ester softening compound, a wetting agent, and a temporary wet strength resin. The process comprises a first step of forming an aqueous papermaking furnish from the above-mentioned components. The second and third steps in the basic process are the deposition of the papermaking furnish onto a foraminous surface such as a Fourdrinier wire and removal of the water from the deposited furnish. An alternate process involves the use of the furnish containing the aforementioned components in a papermaking process which will produce a pattern densified fibrous web having a relatively high bulk field of relatively low fiber density in a patterned array of spaced zones of relatively high fiber density.
Patent DK-0701717-T3 (DK)
Inventor: SHEPHERD KENNETH
IPC: G06F19/00
Filed: 1993-05-28
Granted: 2000-09-04
Abstract: Methods and apparatus which deal with the management of risk relating to specified, yet unknown, future events are disclosed. "Sponsor" stakeholders (12) specify a particular product relating to an event or phenomenon for which there is a range of possible future outcomes. "Ordering" stakeholders (13) then offer contracts relating to the predetermined phenomenon and corresponding range of outcomes. The offered contracts specify an entitlement (or pay-off) at the future time of maturity for each outcome, and a consideration (or premium) payable, in exchange, to a "counter-party" stakeholder (14). Independently of the offered contracts, the "counter-party" stakeholders (14) input data as to their view of the likelihood of occurrence of each outcome in the predetermined range into the future, or specifically at the predetermined date of maturity. Each offered contract is priced by the processing units (20) by calculating counter-party premiums from the registered data, and a match attempted by a comparison of the offered premium with the calculated premiums. Matched contracts can be further traded until maturity, and at-maturity processing handles the exchange of entitlement as between the matched parties to the contract.
Patent DK-0674630-T3 (DK)
Inventor: SKULNICK HARVEY I
IPC: C07F7/18
Filed: 1993-12-13
Granted: 2003-02-24
Abstract: This invention provides 7-deoxy-taxol analogs of Formula I: The compounds of Formula I (including II and III) are useful for the same cancers for which taxol has been shown active, including human ovarian cancer, breast cancer, and malignant melanoma as well as lung cancer, gastric cancer, colon cancer, head and neck cancer, and leukemia.
Patent DK-0697231-T3 (DK)
Inventor: BAUER HANS-PETER
IPC: C02F1/04
Filed: 1995-08-10
Granted: 1999-11-08
Abstract: In the processing and re-use of active washing substances from wash concentrates in the reverse osmosis cleaning of waste laundry water, running in combination with a pptn. combustion plant, the wash concentrate is periodically fed to a spray dryer and the material contg. dry active wash material is recycled to the wash process.
Patent DK-0854694-T3 (DK)
Inventor: CARLSSON LENNART
IPC: A61F2/30
Filed: 1996-10-10
Granted: 2002-04-29
Abstract: PCT No. PCT/SE96/01289 Sec. 371 Date Jun. 12, 1998 Sec. 102(e) Date Jun. 12, 1998 PCT Filed Oct. 10, 1996 PCT Pub. No. WO97/13477 PCT Pub. Date Apr. 17, 1997A holder of a biocompatible material for implantation in bone tissue for controlled receipt and positional fixation of equipment for electrical transfer of information. A cylindrical mounting part is for lying outside of the bone tissue and includes a mounting end and a smooth outer surface. A conical insertion part is for insertion into the bone tissue. The insertion part is narrower than the mounting part and includes an insertion end opposite the mounting end and tapers toward the insertion end at an angle of 0 DEG  to 10 DEG . A conical intermediate part is between the mounting part and the insertion part. A plurality of retention elements are at least on the insertion part for providing good initial anchoring and stability to the holder and for permitting the holder to be mounted in a preprepared hole in the bone tissue without screwing the holder. A channel extends through the holder for receiving the equipment and connections to the equipment and including an exit opening in the insertion part.
Patent DK-0865424-T3 (DK)
Inventor: FAROOQ SALEEM
IPC: C07C239/02
Filed: 1996-11-25
Granted: 2003-01-27
Abstract: Compounds of the formula <CHEM> wherein Y is OCH3 or NHCH3, which can be used as agrochemical active compounds.
Patent DK-0969833-T3 (DK)
Inventor: SEEMANN GERHARD
IPC: A61K31/275
Filed: 1998-03-12
Granted: 2003-09-15
Abstract: Prolongation of the expression of transgenic proteins by immunomodulating treatment The invention relates to the use of one or more immunosuppressants for the production of a pharmaceutical for increasing the tolerance of a mammal to transgenic cells, and to a process for identifying immunosuppressants suitable for this. By the use of pharmaceuticals of this type, the production of the transgenic expression product is markedly prolonged even after discontinuing the immunosuppressant treatment.
Patent DK-1106178-T3 (DK)
Inventor: SAKODA SABURO
IPC: A61K31/437
Filed: 1998-08-10
Granted: 2005-02-28
Abstract: A medicine for treatment of multiple sclerosis comprising, as an effective component, ibudilast represented by the chemical formula (1) below. Ibudilast is effective to experimental autoimmune encephalomyelitis by oral administration, and is effective to multiple sclerosis which is a disease of a central nervous system. <CHEM>
Patent DK-1042508-T3 (DK)
Inventor: WOHLSTADTER JACOB N
IPC: G01N33/533
Filed: 1998-12-17
Granted: 2010-04-26
Abstract: The invention provides a reagent for carrying out ECL assays for an analyte-of-interest comprising an assay-ligand, said assay-ligand being linked to a soluble polymer comprising a plurality of electrochemiluminescence moieties.  Also provided is a complex comprising: (a) an analyte-of-interest; (b) an assay-ligand linked to a soluble polymer, said polymer comprising a plurality of electrochemiluminescent moieties; and (c) an assay ligand immobilized on an electrode.  Further provided is a method for conducting electrochemiluminescence measurements for a binding analyte-of-interest comprising the steps of: (a) forming a complex comprising (i) an assay-ligand linked to a soluble polymer, said polymer comprising a plurality of ECL moieties, said assay-ligand being capable of binding with said analyte or with; (ii) an assay-ligand immobilized on an electrode; and (b) conducting an electrochemiluminescence measurement at said electrode in the presence of electrochemiluminescence reactants.
Patent DK-1246813-T3 (DK)
Inventor: PETERSEN HANS
IPC: C07D307/87
Filed: 1999-12-30
Granted: 2004-03-01
Abstract: The invention provides a new and improved method for the preparation of 5-cyano-phtalid, which is a key intermediate in the preparation of the antidepressant compound citalopram.
Patent ES-2185529-T3 (ES)
Inventor: SAMBROOK JOSEPH F
IPC: C07H21/04
Filed: 1990-03-01
Granted: 2003-05-01
Abstract: The present invention relates to serine protease mutants of the chymotrypsin superfamily, particularly t-PA mutants that are resistant to inhibition by their cognate inhibitors, such as PAI-1 in the case of t-PA, and genes that encode the same. The invention also relates to serine protease inhibitor mutants, particularly PAI-1 mutants that inhibit the serine protease mutants of the present invention, particularly t-PA mutants, and genes that encode the same. The serine protease mutants and serine protease inhibitor mutants are useful as, e.g., pharmacological agents.